T regulatory cell therapy in transplantation: Stability, localization and functional specialization

Current Opinion in Organ Transplantation

Volumn 17, Issue 4, 2012, Pages 343-348

  MacDonald, Katherine G ^a,c   Orban, Paul C ^b,c   Levings, Megan K ^a,c  

^a Departments of Surgery   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

chemokines; stability; T regulatory cells; trafficking; transplantation

Indexed keywords

AZACITIDINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; MACROPHAGE DERIVED CHEMOKINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PADGEM PROTEIN; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; CELL FUNCTION; CELL HOMING; CELL MIGRATION; CELL SPECIFICITY; CELL TRANSPLANTATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; ENGRAFTMENT; EPIGENETICS; GLUCOSE TOLERANCE; HELPER CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; KIDNEY TRANSPLANTATION; LONGEVITY; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; T LYMPHOCYTE SUBPOPULATION;

HUMANS; IMMUNITY, CELLULAR; ISOANTIGENS; ORGAN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TISSUE THERAPY; TRANSPLANTATION TOLERANCE;

EID: 84863824325     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328355aaaf     Document Type: Review

References (57)

1. Polansky JK, Kretschmer K, Freyer J, et al. DNA methylation controls Foxp3 gene expression. Eur J Immunol 2008; 38:1654-1663.
2. Shevach EM. Mechanisms of foxp3-T regulatory cell-mediated suppression. Immunity 2009; 30:636-645.
3. Sakaguchi S, Wing K, Onishi Y, et al. Regulatory T cells: how do they suppress immune responses? Int Immunol 2009; 21:1105-1111.
4. Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27:20-21.
5. Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27:18-20.
6. McMurchy AN, Bushell A, Levings MK, Wood KJ. Moving to tolerance: clinical application of T regulatory cells. Semin Immunol 2011; 23:304-313.
7. Ding Y, Xu J, Bromberg JS. Regulatory T cell migration during an immune response. Trends Immunol 2012; 33:174-180.
8. Campbell DJ, Koch MA. Phenotypical and functional specialization of FOXP3-regulatory T cells. Nat Rev Immunol 2011; 11:119-130.
9. Wei S, Kryczek I, Zou W. Regulatory T-cell compartmentalization and trafficking. Blood 2006; 108:426-431.
10. Ochando JC, Yopp AC, Yang Y, et al. Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3-regulatory T cells. J Immunol 2005; 174:6993-7005.
11. Zhang N, Schröppel B, Lal G, et al. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 2009; 30:458-469.
12. Duhen T, Duhen R, Lanzavecchia A, et al. Functionally distinct subsets of human FOXP3-Treg cells that phenotypically mirror effector TH cells. Blood 2012; 119:4430-4440.
13. Dilek N, Poirier N, Usal C, et al. Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5. J Immunol 188:4209-4216, 2012.
14. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10:942-949.
15. Lee I, Wang L, Wells AD, et al. Recruitment of Foxp3-T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005; 201:1037-1044.
16. Montane J, Bischoff L, Soukhatcheva G, et al. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. J Clin Invest 2011; 121:3024-3028.
17. Muller YD, Ehirchiou D, Golshayan D, et al. Potential of T-regulatory cells to protect xenografts. Curr Opin Organ Transplant 2012; 17:155-161.
18. Chaudhry A, Rudra D, Treuting P, et al. CD4-regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009; 326:986-991.
19. Wohlfert EA, Grainger JR, Bouladoux N, et al. GATA3 controls Foxp3 regulatory T cell fate during inflammation in mice. J Clin Invest 2011; 121:4503-4515.
20. Hoerning A, Koss K, Datta D, et al. Subsets of human CD4(-) regulatory T cells express the peripheral homing receptor CXCR3. Eur J Immunol 2011; 41:2291-2302.
21. dHennezel E, Piccirillo C. Functional plasticity in human FOXP3-regulatory T cells: Implications for cell-based immunotherapy. Hum Vaccin Immunother 2012; 8.
22. Hamann A. Regulatory T cells stay on course. Immunity 2012; 36:161-163.
23. McClymont SA, Putnam AL, Lee MR, et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol 2011; 186:3918-3926.
24. Dominguez-Villar M, Baecher-Allan CM, Hafler DA. Identification of T helper type 1-like, Foxp3-regulatory T cells in human autoimmune disease. Nat Med 2011; 17:673-675.
25. Wei B, Baker S, Wieckiewicz J, Wood KJ. IFN-gamma triggered STAT1-PKB/ AKT signalling pathway influences the function of alloantigen reactive regulatory T cells. Am J Transplant 2010; 10:69-80.
26. Warnecke G, Feng G, Goto R, et al. CD4-regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis. Am J Pathol 2010; 177:464-472.
27. Beriou G, Costantino CM, Ashley CW, et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009; 113:4240-4249.
28. Marwaha AK, Crome SQ, Panagiotopoulos C, et al. Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes. J Immunol 2010; 185:3814-3818.
29. Esplugues E, Huber S, Gagliani N, et al. Control of TH17 cells occurs in the small intestine. Nature 2011; 475:514-518.
30. Zhou X, Bailey-Bucktrout SL, Jeker LT, et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009; 10:1000-1007.
31. Miyao T, Floess S, Setoguchi R, et al. Plasticity of foxp3(-) T cells reflects promiscuous foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 2012; 36:262-275.
32. Rubtsov YP, Niec RE, Josefowicz S, et al. Stability of the regulatory T cell lineage in vivo. Science 2010; 329:1667-1671.
33. dHennezel E, Yurchenko E, Sgouroudis E, et al. Single-cell analysis of the human T regulatory population uncovers functional heterogeneity and instability within FOXP3-cells. J Immunol 2011; 186:6788-6797.
34. Hansmann L, Schmidl C, Kett J, et al. Dominant Th2 differentiation of human regulatory T cells upon loss of FOXP3 expression. J Immunol 2012; 188:1275-1282.
35. Hippen KL, Merkel SC, Schirm DK, et al. Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am J Transplant 2011; 11:1148-1157.
36. Allan SE, Crome SQ, Crellin NK, et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007; 19:345-354.
37. Floess S, Freyer J, Siewert C, et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007; 5:e38.
38. Sanchez-Abarca LI, Gutierrez-Cosio S, Santamaria C, et al. Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting. Blood 2010; 115:107-121.
39. Goodyear OC, Dennis M, Jilani NY, et al. Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia. Blood 2012.
40. Kwon HS, Lim HW, Wu J, et al. Three novel acetylation sites in the foxp3 transcription factor regulate the suppressive activity of regulatory T cells. J Immunol 2012; 188:2712-2721.
41. Liu Y, Wang L, Han R, et al. Two lysines in the forkhead domain of foxp3 are key to T regulatory cell function. PLoS One 2012; 7:e29035.
42. Beier UH, Wang L, Bhatti TR, et al. Sirtuin-1 targeting promotes Foxp3-Tregulatory cell function and prolongs allograft survival. Mol Cell Biol 2011; 31:1022-1029.
43. Kendal AR, Waldmann H. Infectious tolerance: therapeutic potential. Curr Opin Immunol 2010; 22:560-565.
44. Andersson J, Tran DQ, Pesu M, et al. CD4-FoxP3-regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J Exp Med 2008; 205:1975-1981.
45. Kendal AR, Chen Y, Regateiro FS, et al. Sustained suppression by Foxp3-regulatory T cells is vital for infectious transplantation tolerance. J Exp Med 2011; 208:2043-2053.
46. Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011; 117:1061-1070.
47. Sharif-Paghaleh E, Sunassee K, Tavare R, et al. In vivo SPECT reporter gene imaging of regulatory T cells. PLoS One 2011; 6:e25857.
48. Ribas A, Koya RC. Adoptive cell transfer of T-cell receptor-engineered lymphocytes: lessons from recent modeling. Future Oncol 2010; 6:1671-1673.
49. Kalos M, Levine BL, Porter DL, et al. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med 2011; 3:95ra73.
50. Webster KE, Walters S, Kohler RE, et al. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J Exp Med 2009; 206:751-760.
51. Boyman O, Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 2012; 12:180-190.
52. Koreth J, Matsuoka K, Kim HT, et al. Interleukin-2 and regulatory T cells in graftversus-host disease. N Engl J Med 2011; 365:2055-2066.
53. Ma A, Qi S, Song L, et al. Adoptive transfer of CD4-CD25-regulatory cells combined with low-dose sirolimus and antithymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys. Int Immunopharmacol 2011; 11:618-629.
54. Hippen KL, Merkel SC, Schirm DK, et al. Massive ex vivo expansion of human natural regulatory T cells (Tregs) with minimal loss of in vivo functional activity. Sci Transl Med 2011; 3:ra41.
55. Lamming DW, Ye L, Katajisto P, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 2012; 335:1638-1643.
56. Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants. Am J Transplant 12:1133-1145, 2012.
57. Stauch D, Yahyazadeh A, Bova R, et al. Induction of bona fide regulatory T cells after liver transplantation -the potential influence of polyclonal antithymocyte globulin. Transpl Int 2012; 25:302-313.